Vonvendi inj 1 iu vwf:rco
Products billed under this code include Vonvendi.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Vonvendi.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vonvendi | Takeda Pharmaceuticals America, Inc. | 00944-7551-02 | 1 | $1.826 |
| Vonvendi | Takeda Pharmaceuticals America, Inc. | 00944-7553-02 | 1 | $1.826 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.826 | +$0.015 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted September 17, 2026 |
| 3Q26 | $1.811 | −$0.019 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted September 15, 2026 |
| 2Q26 | $1.83 | −$0.006 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted September 15, 2026 |
| 1Q26 | $1.836 | −$0.016 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted September 15, 2026 |
| 4Q25 | $1.852 | +$0.006 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted September 8, 2026 |
| 3Q25 | $1.846 | +$0.015 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted March 10, 2026 |
| 2Q25 | $1.831 | −$0.02 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted March 10, 2026 |
| 1Q25 | $1.851 | −$0.02 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted December 19, 2025 |
| 4Q24 | $1.871 | +$0.044 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 11, 2025 |
| 3Q24 | $1.827 | −$0.042 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 11, 2025 |
| 2Q24 | $1.869 | +$0.046 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted March 11, 2025 |
| 1Q24 | $1.823 | −$0.009 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted December 19, 2024 |
| 4Q23 | $1.832 | +$0.051 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted October 10, 2024 |
| 3Q23 | $1.781 | −$0.084 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 5, 2024 |
| 2Q23 | $1.865 | +$0.064 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted February 23, 2024 |
| 1Q23 | $1.801 | −$0.001 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted December 6, 2023 |
| 4Q22 | $1.802 | −$0.056 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 22, 2023 |
| 3Q22 | $1.858 | +$0.053 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 9, 2023 |
| 2Q22 | $1.805 | −$0.037 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted December 14, 2022 |
| 1Q22 | $1.842 | −$0.01 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 8, 2022 |
| 4Q21 | $1.852 | +$0.058 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 2, 2022 |
| 3Q21 | $1.794 | −$0.089 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted June 2, 2022 |
| 2Q21 | $1.883 | −$0.007 | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted March 1, 2022 |
| 1Q21 | $1.89 | – | 1 IU | Vonvendi inj 1 iu vwf:rco | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.